loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 22383 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 INDACATEROL MALEATE (1)

filter

01 NOVARTIS (1)

filter

01 POWDER;INHALATION (1)

filter

01 EQ 75MCG BASE (1)

filter

01 USA (1)

URL Supplier Web Content
POWDER;INHALATION
EQ 75MCG BASE
ARCAPTA NEOHALER
USA
22383
2011-07-01
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 22383

Looking for CTD TGA MCC DOSSIER APPLICATION 22383 1

19

Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is INDACATEROL MALEATE, with a corresponding application number 22383 and regulatory information .

proudly manufactured in the

approval since 2011-07-01

Novartis Pharmaceuticals Corporation's ARCAPTA NEOHALER POWDER;INHALATION, medication with EQ 75MCG BASE of INDACATEROL MALEATE.

Post Enquiry
POST ENQUIRY